drugset
drugset / Trial / NCT07001800

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

NCT07001800 ↗

Phase 2/3 Recruiting 1276 enrolled Kardigan, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.

Timeline

Start
2025-06-27
Primary completion
2028-08-31
Completion
2030-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ataciguat Small molecule — —

Indications

aortic valve stenosis